Therapeutic potential of complement inhibitors in myocardial ischaemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.5, 2000-05, pp. : 975-991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potassium Channel Openers in Myocardial Ischaemia: Therapeutic Potential of Nicorandil

By Gomma A.H. Purcell H.J. Fox K.M.

Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. : 1705-1710

Adis International

Access to resources Recommend Favorite

The therapeutic potential of aromatase inhibitors

By Miller WR Jackson J

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 337-351

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of post-ischaemic inflammation as a therapeutic approach to myocardial ischaemia reperfusion injury

By Kupatt C. Wichels R. Becker B. Boekstegers P.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1395-1404

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of target of rapamycin inhibitors

By Easton John B Houghton Peter J

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential for phospholipase A2 inhibitors

By Mayer R.J. Marshall L.A.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite